CHICAGO, IL, May 15, 2014 /24-7PressRelease/
-- Rep. Jan Schakowsky visited Wockhardt's Morton Grove facility with a goal in mind: strengthening efforts to revitalize American manufacturing. Following a presentation of the facility's history, Representative Schakowsky toured the plant and inaugurated the Oral Solid facility that was created with $14 million capital investment. The facility is dedicated to the production of affordable, generic oral solid dose products.
In addition to the new Oral Solid Dose facility at Morton Grove, Wockhardt has recently added a new laboratory for Research & Development and additional laboratory space for Quality Control. With the recent acquisition of 9 acres of land adjacent to its existing facility, Wockhardt is poised to continue its rapid expansion in Morton Grove and increase the number of new jobs to the Morton Grove facility.
Wockhardt acquired Morton Grove Pharmaceuticals (MGP) in 2007.
Over the past 45 years, starting from its roots in India, Wockhardt has grown to a billion dollar worldwide organization, today spanning 14 countries in 5 continents. More than 7,900 employees working in offices, 14 manufacturing facilities, 5 research centers, and hospitals are completely dedicated to building an important trust in our products.
(973) 257-4992Email Us Here